Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults
Authors
Craig S. Anderson (ORCID: https://orcid.org/0000-0002-7248-4863)
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults
Craig S. Anderson, Ying Xu, Anthony Rodgers, Kimberley Bassett et al.
Citations
1 citations
Journal
BMJ Open
Topics
Blood Pressure and Hypertension Studies
Field-Weighted Citation Impact (FWCI)
0.40
article
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults
Craig S. Anderson, Ying Xu, Anthony Rodgers, Kimberley Bassett, Menglu Ouyang, Ruth S. Freed, Mark Woodward, Katie Harris, Luke Clancy, John Chalmers, Richard I. Lindley, Sharon L. Naismith, Cheryl E. Carcel, Camilla M. Hoyos, Ruth Peters, Aisling Byrne
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 14(8)
Institutions
The University of Sydney (AU), The George Institute for Global Health (GB), Royal Prince Alfred Hospital (AU), UNSW Sydney (AU), The George Institute for Global Health (AU), Westmead Institute (AU), George Institute for Global Health (CN), Imperial College London (GB), Neuroscience Research Australia (AU)
Funders
Medical Research Council, National Health and Medical Research Council
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults — Craig S. Anderson, Ying Xu, et al. · BMJ Open (2024) | TGRS Research Map | TGRS